Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

• Status: Not yet recruiting
• Trial end date: 2021-10-16
• Target enrollment: 0
• Participant gender: Female

Summary

Efficacy of sublingual versus vaginal misoprostol in termination of first trimester missed abortion

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• Women with an ultrasound diagnosis of missed abortion < 13 weeks gestation without any clinical criteria of Inevitable abortion.

Exclusion Criteria:

• Patients refused the medical treatment.

• Patients have contraindications of the drug (Misoprostol).

• Missed abortion associated with any signs of sepsis